The bill, H.B. No. 1797, introduces Chapter 621 to the Government Code, establishing new regulations regarding drug testing and prescription drug policies for employees and independent contractors of state agencies and political subdivisions in Texas, specifically concerning the medical use of low-THC cannabis and hemp. Key provisions include definitions of terms such as "drug test," "hemp," and "low-THC cannabis," as well as exceptions for peace officers and employees subject to federal drug testing regulations. The bill prohibits state agencies and political subdivisions from requiring drug tests for cannabinoids as a condition of employment or contract, and it protects employees' rights to prescribe or use low-THC cannabis and consumable hemp products.

Additionally, the bill emphasizes medical privacy by preventing agencies from inquiring about employees' use of low-THC cannabis or hemp and mandates compliance with relevant privacy laws. It provides legal recourse for individuals who experience violations of these provisions, allowing them to seek compensatory damages, injunctive relief, and other appropriate remedies. The bill also waives sovereign immunity for claims related to these violations, ensuring that individuals can hold state agencies accountable. The provisions of this act will take effect on September 1, 2025.

Statutes affected:
Introduced: ()